Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.57 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.48 |
| ▸ | RAD52 | P43351 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 6/20 | 0.47 |
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2476775 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL30037693 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL18917031 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL666140 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL30801428 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL417576 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL29388642 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL30059530 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL2477982 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 | |
| SCHEMBL3161061 | 1.00 | NAAA (0.57) | NAAAEPHX1TSHRHCAR2RAD52 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 662 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4614649-A1 | ELECTROLYTIC SOLUTION FOR LITHIUM ION SECONDARY BATTERIES, AND LITHIUM ION SECONDARY BATTERY | Kyocera Corporation (JP) | 2025-09-10 | — | — | EP | claimed |
| EP-4611091-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM-ION SECONDARY BATTERY USING SAME | Kyocera Corporation (JP) | 2025-09-03 | — | — | EP | claimed |
| EP-4611105-A1 | NONAQUEOUS ELECTROLYTE AND CLAY-TYPE LITHIUM ION SECONDARY BATTERY USING SAME | Kyocera Corporation (JP) | 2025-09-03 | — | — | EP | claimed |
| CN-120092348-A | Nonaqueous electrolyte solution and lithium ion secondary battery using same | 京瓷株式会社 | 2025-06-03 | — | — | CN | claimed |
| CN-120092347-A | Nonaqueous electrolyte and clay-type lithium ion secondary battery using same | 京瓷株式会社 | 2025-06-03 | — | — | CN | claimed |
| WO-2024096043-A1 | ELECTROLYTIC SOLUTION FOR LITHIUM ION SECONDARY BATTERIES, AND LITHIUM ION SECONDARY BATTERY | 京セラ株式会社 | 2024-05-10 | — | — | WO | claimed |
| WO-2024090574-A1 | NONAQUEOUS ELECTROLYTE AND CLAY-TYPE LITHIUM ION SECONDARY BATTERY USING SAME | 京セラ株式会社 | 2024-05-02 | — | — | WO | claimed |
| WO-2024090573-A1 | NON-AQUEOUS ELECTROLYTE SOLUTION AND LITHIUM-ION SECONDARY BATTERY USING SAME | 京セラ株式会社 | 2024-05-02 | — | — | WO | claimed |
| US-11652240-B1 | Solid-state electrochemical cells comprising coated negative electrodes and methods of fabricating thereof | GRU Energy Lab Inc. (US) | 2023-05-16 | — | — | US | claimed |
| US-9647294-B2 | Non-aqueous electrolytic solution, electrochemical element using same, and alkynyl compound used therefor | UBE INDUSTRIES, LTD. (JP) | 2017-05-09 | — | — | US | claimed |
| US-7615316-B2 | Nonaqueous electrolytic solution and lithium secondary batteries | UBE INDUSTRIES, LTD. (JP) | 2009-11-10 | — | — | US | claimed |
| EP-1361622-B1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERIES | UBE INDUSTRIES (JP) | 2008-06-04 | — | — | EP | claimed |
| US-20080050658-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERIES | UBE INDUSTRIES, LTD. (JP) | 2008-02-28 | — | — | US | claimed |
| US-7294436-B2 | Nonaqueous electrolytic solution and lithium secondary batteries | UBE INDUSTRIES, LTD. (JP) | 2007-11-13 | — | — | US | claimed |
| US-20040121239-A1 | Nonaqueous electrolytic solution and lithium secondary batteries | UBE INDUSTRIES, LTD. (JP) | 2004-06-24 | — | — | US | claimed |
| EP-1361622-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERIES | Ube Industries, Ltd. (JP) | 2003-11-12 | — | — | EP | claimed |
| CN-122028890-A | Compacted powder having a powdery phase, a hydrophilic gelling agent, an organopolysiloxane elastomer gel, a nonionic surfactant having an HLB of 8.0 or less, a lysophospholipid and a non-volatile oil | 莱雅公司 | 2026-05-12 | — | — | CN | disclosed |
| US-12620620-B2 | Layered gel-polymer electrolytes and methods of forming thereof | GRU Energy Lab Inc. (US) | 2026-05-05 | — | — | US | disclosed |
| EP-1311018-A1 | NONAQUEOUS ELECTROLYTIC SOLUTION AND LITHIUM SECONDARY BATTERY | Ube Industries, Ltd. (JP) | 2003-05-14 | — | — | EP | disclosed |
| US-4065510-A | LITHIUM PHOSPHATE CATALYST | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DT) | 1977-12-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12620620-B2 | Layered gel-polymer electrolytes and methods of forming thereof | LNPK, EPCAM, SLC6A9 | NAAA 2731/4885EPHX1 1518/4885TSHR 4344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.